Skip to main content
OpenTrials
Completed

NCT Number: NCT02521675

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions

There is no specific recommendations on the adjustments of the insulin treatment in the event of physical activity (PA) in T1D patients treated on insulin pump therapy. Patients often prefer additional carbohydrates intake rather than the reduction of their insulin doses because of the lack of specific algorithms.

The DIABRASPORT 2 study aims to demonstrate that using algorithms DIABRASPORT, during a week of physical activity (PA), the incidence of hypoglycaemia is not different from that obtained during a week of rest without physical activity.

It is a multi-center European, controlled, randomized, cross-over, study, in 100 T1D patients practicing an occasional AP.

25 centers involved in this study.

After agreeing to participate in the study, patients will read the information leaflet, ask questions to the investigator physician and they will date and sign the consent form. The investigator physician will do the same.

They will be then drawn randomly via the electronic CRF (eCRF) to determine the order in which they will realize the rest vs DIABRASPORT sessions.

The study will take place in 5 weeks:

During the weeks Baseline and Diabrasport, patients will have to make 3 physical activity of 30 to 60 minutes separated by at least 24 hours:

* moderate activity 3 hours after lunch * intense activity 3 hours after lunch * activity moderate 90 min after lunch They will use their usual algorithms (Cho intake or adjustment of the dose of insulin) during the week Baseline and they will use the Diabrasport algorithm during the week Diabrasport.

Patients will be equipped with a holter Glycemic iPro2, Medtronic, whose data are hidden.

During the week of rest, patients should do no physical activity during the week. They will be equipped with the Glycemic holter.

Patients will have to fill a food survey the days they practice PA. Between each period, the patient must respect a period of wash-out for one week at least, during which he will be asked to not practice physical activity.

Validation of algorithms simple, easy to implement, adaptable by patients, could help to improve balance metabolic and practice of sport among the T1D.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type I Adjustment of Basal Insulin Flow Rate During Physical Activity Adjustment of Prandial Insulin in Case of Physical Activity Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Universitaire, Angers, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged over 18 years
  • Patient with type 1 diabetes for at least 1 year
  • Patient receiving insulin pump under basal-prandial regimen for at least 3 months
  • Patient practicing functional insulin therapy, or using a fixed plane defined food
  • Patients with a stable basal rate for at least 1 week
  • Patient practicing regular physical activity and reproducible identically
  • Patient with HbA1c older than 3 months between 6.5% and 9.5% (HbA1c ≤ 6.5% ≤ 9.5%)
  • Patients with BMI ≤ 35
  • Patient who agreed to participate in the study and who signed an informed consent
  • Patient not participating in another protocol
  • Patient covered by social security

Exclusion criteria

  • Patients with a history of severe hypoglycemia without accidental cause in the 6 months preceding the entry in the protocol
  • Patient not receiving its hypoglycaemia below the threshold of 0.5 g / L
  • Patient with perforating foot ulcer or a known history of heart disease or obliterative arteriopathy of the lower limbs, or a history of cerebrovascular accident, or ongoing proliferative retinopathy or renal failure
  • Patient with poorly controlled hypertension
  • Pregnant woman
  • Patients deprived of liberty by judicial or administrative decision, patients placed under legal guardianship

Treatment and study plan

Usual algorithm

Behavioral

The patient will be fitted with a CGMS (continuous glucose monitoring system) (data not shown) and it will be given the booklet to collect events + food survey

The patient goes home and he must perform 3 physical activities during the week (30-60 minutes) using its usual algorithms (glucose administration or adaptation of the BR), in the afternoon, and spacing them at least 24 hours :

  • Moderate activity 3 hours after lunch
  • Intense activity 3 hours after lunch
  • Moderate activity 90 min after lunch These activities should not exceed 1 hour in wherever possible

Diabrasport algorithm

Behavioral

The patient will be fitted with a CGMS (data not shown) and it will be given the booklet to collect events + food survey

The patient goes home and he must perform 3 physical activities during the week (identical to those carried out during the week "test algorithms usual" and during comparable periods) using DIABRASPORT algorithms, the afternoon and in the spacing at least 24 hours:

  • Moderate activity 3 hours after lunch
  • Intense activity 3 hours after lunch
  • Moderate activity 90min after lunch These activities shall not exceed one hour

Rest

Behavioral

The patient will be fitted with a CGMS (data not shown) and it will be given the booklet to collect events + food survey.

The patient goes home and he will not perform any physical activity during the week

Holter Glycemic Ipro2, Medtronic

Device

Primary outcomes

  1. the number of hypoglycemic events, defined by any threshold crossing 60 mg / dL (3.33mmol / L), measured in the interstitial glucose sensor continuously over a period of 24h

    Time frame: 24h

  2. percentage of time spent over 24 hours in the euglycemic range [70; 180] mg / dL ([3.89, 10] mmol / L)

    Time frame: 24h

  3. percentage of time spent over 24 hours in hyperglycemia (> 180 mg / dL) (> 10 mmol / L)

    Time frame: 24h

Secondary outcomes

  1. Number of hypoglycemic events, defined by any threshold crossing 70 mg / dL (3.9 mml / L), and <54 mg / dL (3 mmol / l) measured by interstitial continuous glucose sensors

    Time frame: 1 week

  2. Number of hyperglycemic events, defined by any crossing of the threshold of 180 mg / dL (10 mml / L), measured by continuous interstitial glucose sensors.

    Time frame: 1 week

  3. Metabolic goals analysis:

    Time frame: 1 week

    • percentage of time spent in the intervals [70; 180] and [80; 140] mg / dL, [3.89; 10] and [4.44; 7.78] mmol / L
    • percentage of time passes hypoglycemia (<60mg / dL) (<3.33 mmol / L)
    • percentage of time spent in hypoglycemia (<54mg / dL) (<3 mmol / L)
    • percentage of time spent in hypoglycemia (<70mg / dL) (<3.89 mmol / L)
    • percentage of time spent <80 mg / dL; (<4.44 mmol / L)
    • percentage of time spent in hyperglycemia (> 180 mg / dL) (> 10 mmol / L)
    • percentage of time spent> 140 mg / dL (> 7.78 mmol / L)

  4. Nadirs analysis of blood glucose during the night (value reached)

    Time frame: 1 week

  5. Nadirs analysis of blood glucose during the night (time to onset)

    Time frame: 1 week

  6. Analysis of quantities of glucose administration consumed during and at the waning of physical activity

    Time frame: 1 week

  7. Comparison of average values of continuous glucose measurements according to the period (DIABRASPORT, rest and Baseline) and at different times of the day and night.

    Time frame: 1 week

  8. Analysis by subgroups, depending on the type of physical activity and its duration, a link between a typology of physical activity or patients, and the number of hypoglycemia events during or waning of physical activity

    Time frame: 1 week

  9. Analysis of evaluation questionnaires intensity PA (Borg) and quality of life (EVA)

    Time frame: 1 week

  10. Comparison between number of hypoglycemic events predicted by the prediction function "DIABRASPORT" and number of hypoglycemic events actually occurred.

    Time frame: 1 week

Sponsors and collaborators

Lead sponsor

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Other

Registry information

Official study title

Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity

Acronym: Diabrasport2

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Aug 13, 2015
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.